FTC Supports NIST Framework, Urges Further Action On Patent Reform

By Gabrielle Wanneh / February 12, 2024 at 2:06 PM
The Federal Trade Commission (FTC) welcomes the Biden administration’s efforts to implement a new guidance framework that would permit government agencies to consider the price of an invention when deciding whether to invoke their federal authority to override the privately-held patent of an invention, but is urging the administration to also take action against drug industry patent abuses to further ensure lower prescription drug costs for patients and the government. The commission’s Feb. 6 comments supporting the administration’s draft march-in...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.